Hematopoietic Stem Cell Transplantation (HSCT) is an advanced treatment used for certain blood cancers, bone marrow disorders, immune system disorders and other serious conditions affecting blood-forming cells. It involves replacing damaged or diseased blood-forming stem cells with healthy stem cells obtained either from the patient or a suitable donor.
Hematopoietic stem cells are responsible for Hematopoietic Stem Cell Transplantation: Types, Procedure, Benefits, Risks and Recovery
producing red blood cells, white blood cells and platelets. When these cells are severely damaged by disease or intensive chemotherapy, hematopoietic stem cell transplantation can help restore the body’s ability to produce healthy blood cells.
For patients considering stem cell transplantation in Chennai, understanding the procedure, types, eligibility, risks and recovery process can help them discuss appropriate treatment options with their medical team.
What Is Hematopoietic Stem Cell Transplantation?
Hematopoietic stem cell transplantation, commonly called HSCT, is a medical procedure in which healthy blood-forming stem cells are infused into a patient to restore bone marrow function.
The transplanted stem cells can come from:
- The patient’s own body
- A related or unrelated donor
- An identical twin in selected cases
- Umbilical cord blood in selected situations
The stem cells may be collected from peripheral blood, bone marrow or cord blood. After infusion, the cells travel to the bone marrow and begin producing new blood cells.
Unlike an organ transplant, the stem cells are generally given through an intravenous catheter, similar to a blood transfusion.
Why Is Hematopoietic Stem Cell Transplantation Done?
HSCT may be considered when intensive treatment is required or when the patient’s bone marrow or blood-forming system is severely affected.
It may be used in the treatment of selected:
- Leukemias
- Lymphomas
- Multiple myeloma
- Myelodysplastic syndromes
- Aplastic anemia
- Sickle cell disease
- Certain immune system disorders
- Selected inherited blood disorders
The suitability of HSCT depends on several factors, including the disease, stage of disease, previous treatment, overall health, availability of a donor and the patient’s ability to tolerate intensive therapy.
Therefore, not every patient with a blood disorder requires a stem cell transplant. A hematologist or transplant specialist evaluates each patient individually before recommending HSCT.
Types of Hematopoietic Stem Cell Transplantation
There are several types of hematopoietic stem cell transplantation. The two major types are autologous HSCT and allogeneic HSCT.
For more information about the different transplant approaches, see Types of Transplant.
1. Autologous Stem Cell Transplant
In an autologous stem cell transplant, the patient’s own healthy stem cells are collected and stored before intensive treatment.
The general process involves:
- Mobilizing stem cells into the bloodstream.
- Collecting the stem cells through a procedure called apheresis.
- Processing and storing the collected stem cells.
- Giving high-dose chemotherapy or another preparative treatment.
- Infusing the stored stem cells back into the patient.
The transplanted cells help restore blood-forming function after intensive treatment. Autologous transplantation is commonly used for selected blood cancers, including multiple myeloma and some lymphomas.
2. Allogeneic Stem Cell Transplant
In an allogeneic stem cell transplant, the stem cells come from another person. The donor may be a family member or an unrelated donor who has an appropriate tissue match.
Before transplantation, doctors perform tests to determine compatibility between the donor and recipient. Human leukocyte antigen, or HLA, matching is an important part of donor selection.
Allogeneic transplantation may be recommended for certain leukemias, lymphomas and other blood or immune system disorders.
One important potential benefit of an allogeneic transplant is the graft-versus-leukemia or graft-versus-tumor effect, in which donor immune cells may recognize and attack remaining cancer cells.
3. Syngeneic Transplant
A syngeneic transplant uses stem cells from an identical twin. This type of transplantation is relatively uncommon and is possible only when the patient has an identical twin who can serve as a donor.
Where Do Stem Cells Come From?
Stem cells used for HSCT can be collected from different sources.
Peripheral Blood Stem Cells
Peripheral blood stem cells are collected from the bloodstream using an apheresis machine. The machine separates stem cells from the blood and returns the remaining blood components to the donor or patient.
Peripheral blood is a commonly used source of stem cells for transplantation.
Bone Marrow
Bone marrow contains blood-forming stem cells. Stem cells can be collected directly from the bone marrow when appropriate.
Umbilical Cord Blood
Cord blood collected after childbirth can also provide blood-forming stem cells for selected patients.
The choice of stem cell source depends on the patient’s condition, transplant type, donor availability and the transplant team’s assessment.
How Does the HSCT Procedure Work?
The hematopoietic stem cell transplant procedure generally involves several stages. Patients can learn more about the individual stages in the hospital’s Transplant Procedure guide.
Step 1: Evaluation and Testing
Before transplantation, the medical team evaluates the patient’s overall health and disease status. Tests may include blood investigations, imaging, heart and lung assessments and other examinations depending on the patient’s condition.
For allogeneic transplantation, donor testing and HLA matching are also performed.
Step 2: Stem Cell Collection
For autologous transplantation, the patient’s stem cells are collected and stored before intensive treatment.
For allogeneic transplantation, stem cells are collected from the selected donor.
Step 3: Conditioning Treatment
The patient receives a preparative or conditioning regimen, which may involve high-dose chemotherapy and, in some cases, radiation therapy.
This treatment is designed to treat the underlying disease and prepare the body for the transplant.
Step 4: Stem Cell Infusion
The stem cells are infused through an intravenous catheter. This stage is often referred to as Day 0 of the transplant process.
The infusion itself is generally similar to receiving blood through an IV line.
Step 5: Engraftment and Recovery
After infusion, the stem cells travel to the bone marrow and begin producing new blood cells. This process is called engraftment.
During this period, doctors closely monitor blood counts, infections, bleeding and other possible complications.
What Are the Benefits of HSCT?
The potential benefits of hematopoietic stem cell transplantation depend on the underlying disease and the type of transplant.
Potential benefits may include:
- Restoring blood-forming stem cells after intensive treatment
- Providing a treatment option for certain blood cancers
- Replacing damaged or diseased bone marrow
- Supporting recovery of blood cell production
- Providing a potential donor immune response against certain cancers in allogeneic transplantation
- Offering a treatment option for selected non-malignant blood and immune disorders
HSCT can be an intensive treatment, so the potential benefits must always be weighed against possible complications.
What Are the Risks and Side Effects of HSCT?
Like any major medical treatment, stem cell transplantation can have side effects. The risks vary according to the patient’s disease, age, overall health, conditioning regimen and transplant type.
For additional information, patients can read about risks and complications of bone marrow transplantation.
Possible short-term side effects include:
- Fatigue
- Nausea and vomiting
- Reduced appetite
- Mouth sores
- Hair loss
- Increased risk of infection
- Low blood counts
- Bleeding
- Skin reactions
Long-term complications can include fertility problems, organ-related complications and other health effects.
Patients receiving an allogeneic transplant may also develop graft-versus-host disease (GVHD). GVHD occurs when donor immune cells recognize the recipient’s tissues as foreign and attack them. It can affect organs such as the skin, liver and gastrointestinal tract.
Because complications can be serious, HSCT should be performed in a specialized transplant centre with appropriate monitoring and supportive care.
Recovery After Hematopoietic Stem Cell Transplantation
Recovery after HSCT is gradual and differs from patient to patient.
During the initial recovery period, patients may require close monitoring of blood counts, infection symptoms, nutrition and other potential complications.
Once the transplanted stem cells begin producing blood cells, blood counts gradually recover. However, recovery of the immune system can take considerably longer.
Regular follow-up appointments are important during this period. The transplant team may monitor blood counts, disease status, infections, medication effects and other aspects of recovery.
Patients and caregivers can also learn more about post-transplant care and survivorship to understand the importance of continued monitoring after transplantation.
Choosing a Stem Cell Transplant Centre
Choosing the right stem cell transplant hospital in Chennai is an important decision. Patients and families may consider factors such as:
- Experience of the transplant team
- Availability of hematology and oncology specialists
- Dedicated transplant facilities
- Infection-control protocols
- Availability of intensive supportive care
- Laboratory and diagnostic facilities
- Donor matching and stem cell collection services
- Long-term follow-up and monitoring
Patients should discuss their diagnosis and treatment options with a qualified hematologist or transplant specialist before making a treatment decision.
Those looking for a specialist can learn more about the bone marrow transplant doctors in Chennai and the transplant services available at Kannappa Memorial Hospital.
Hematopoietic Stem Cell Transplantation in Chennai
For patients searching for hematopoietic stem cell transplantation in Chennai, access to experienced hematology specialists and dedicated transplant care is important.
Kannappa Memorial Hospital provides bone marrow transplant and hematology care in Chennai, including evaluation and treatment for patients who may require transplantation.
A transplant is not a single procedure but a complete treatment journey involving evaluation, stem cell collection, conditioning therapy, stem cell infusion, engraftment and long-term follow-up.
At Kannappa Memorial Hospital, patients can discuss their blood disorder or cancer diagnosis with the appropriate medical team and understand whether stem cell transplantation may be suitable for their individual condition.
The decision to undergo HSCT should always be based on a detailed medical evaluation and a personalized discussion between the patient, family and transplant team.
Conclusion
Hematopoietic Stem Cell Transplantation (HSCT) is an important treatment option for selected patients with blood cancers, bone marrow disorders and certain other serious diseases. Depending on the condition, patients may receive an autologous transplant using their own stem cells or an allogeneic transplant using stem cells from a suitable donor.
The HSCT journey includes detailed evaluation, stem cell collection, conditioning treatment, transplantation, engraftment and long-term follow-up. Although transplantation can involve significant risks, advances in transplant medicine, donor matching and supportive care continue to improve the management of patients undergoing this treatment.
If you or a family member has been advised to consider a hematopoietic stem cell transplant, consult a qualified hematologist or transplant specialist to understand the potential benefits, risks and alternatives based on the individual medical condition.
Frequently Asked Questions About Hematopoietic Stem Cell Transplantation
1. What is hematopoietic stem cell transplantation?
Hematopoietic stem cell transplantation is a treatment in which healthy blood-forming stem cells are infused into a patient to restore blood and bone marrow function after intensive treatment or for certain blood disorders.
2. What is the difference between HSCT and bone marrow transplantation?
HSCT is a broader term for transplantation of blood-forming stem cells. These cells may come from peripheral blood, bone marrow or cord blood. A bone marrow transplant specifically refers to stem cells obtained from bone marrow.
3. What is an autologous stem cell transplant?
An autologous transplant uses the patient’s own stem cells. They are collected before intensive treatment, stored and later infused back into the patient.
4. What is an allogeneic stem cell transplant?
An allogeneic transplant uses healthy blood-forming stem cells from another person, such as a suitable related or unrelated donor.
5. How are stem cells collected?
Stem cells can be collected from peripheral blood using apheresis, from bone marrow or, in selected circumstances, from umbilical cord blood.
6. How long does recovery take after HSCT?
Recovery varies between individuals and depends on the type of transplant and overall health. Blood counts generally recover as the transplanted cells engraft, while complete immune recovery can take much longer.
7. Is hematopoietic stem cell transplantation suitable for everyone?
No. Eligibility depends on the disease, disease status, previous treatments, overall health, donor availability and other medical factors. A transplant specialist must evaluate each patient individually.
8. Where can I seek hematopoietic stem cell transplantation in Chennai?
Patients looking for hematopoietic stem cell transplantation in Chennai should consult a specialized hematology or transplant centre where the medical team can evaluate the diagnosis and determine whether HSCT is an appropriate treatment option. Learn more about bone marrow transplant services at Kannappa Memorial Hospital.
